Alkem Laboratories Limited

SBI Mutual Fund decreased its stake in Alkem Laboratories from 2.42% to 1.99%, selling 508,608 shares for ₹283.05 crore at ₹5563.00 apiece.

A pharmaceutical company engaged in the development, manufacture, and sale of drugs and nutraceutical products across global markets. The company operates research-driven facilities to serve both domestic and international customers with a focus on therapeutic innovation. Its distinctive approach combines pharmaceutical manufacturing expertise with nutraceutical offerings to address diverse healthcare needs and patient populations worldwide.

India's largest AMC by total AUM, managing over Rs 11 lakh crore across equity, debt and hybrid schemes. Backed by State Bank of India, the country's largest bank, which gives it unmatched retail reach across every Indian state. With over 70 schemes and 50 million folios, SBI MF's positioning moves are tracked as a proxy for domestic institutional flows.